Benjamin Zeskind

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Benjamin Zeskind

Benjamin Zeskind is recorded as CEO and Board Member at Immuneering Corp (IMRX). The proxy statement of Immuneering Corp reports total compensation of $1,660,612 for Benjamin Zeskind in fiscal 2025, including a base salary of $641,493. Disclosed compensation is on record for 6 fiscal years. Benjamin Zeskind has spoken on 2 earnings calls across 1 company, most recently for Immuneering Corp on November 12, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Benjamin Zeskind's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Immuneering Corp (IMRX)
Board Member

Proxy statement

Current
2008-01-01–present
Immuneering Corp (IMRX)
CEO

Proxy statement

Current
Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Immuneering Corp

IMRX

Current role

CEO, Board Member

2008-01-01–present

2 appearances Latest appearance 2025-11-12

View calls and events

Leadership on record at Immuneering Corp

Other people whose current roles at this company are on record from its filings.

Andrew Gengos CFO
Biren Amin CFO
Michael D. Bookman General Counsel, Board Member
Mallory Morales Chief Accounting Officer, Board Member
Brett Hall Board Member
Harold E. Brakewood Board Member
Igor Matushansky Board Member
Laurie B. Keating Board Member
Leah R. Neufeld Board Member
Peter Feinberg Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Immuneering Corp (IMRX)	President and Chief Executive Officer	$641,493	$423,385	—	$579,504	—	$16,230	$1,660,612
2024	Immuneering Corp (IMRX)	President and Chief Executive Officer	$616,820	$308,410	—	$1,003,776	—	$16,086	$1,945,092
2023	Immuneering Corp (IMRX)	President and Chief Executive Officer	$593,096	$326,203	—	$983,116	—	$15,786	$1,918,201
2022	Immuneering Corp (IMRX)	President and Chief Executive Officer	$570,285	$313,657	—	$1,156,550	—	$14,474	$2,054,966
2021	Immuneering Corp (IMRX)	President and Chief Executive Officer	$400,238	$421,041	—	$1,052,035	—	$18,492	$1,891,806
2020	Immuneering Corp (IMRX)	President and Chief Executive Officer	$292,550	$500,000	—	—	—	$13,495	$806,045

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call Immuneering Corp Q3 FY2025 Earnings Call Immuneering Corp (IMRX)
2025-11-12
Earnings call Immuneering Corp Q4 FY2022 Earnings Call Immuneering Corp (IMRX)
2023-03-06